SEC 13F Intelligence

A.r.t. Advisors, LLC / REGN

A.r.t. Advisors, LLC’s Regeneron Pharmaceuticals Position

Does A.r.t. Advisors, LLC own Regeneron Pharmaceuticals (REGN)? Not currently — the last reported position was 398 shares worth $222,000 in Q2 2021; the fund’s latest 13F (Q3 2021) no longer reports it.

Position Value
$222,000
Q2 2021
Shares
398
% of Portfolio
+9.63%
Quarters Held
5
position exited

Position History REGN

Reported value by quarter
Q1 ’19: $2MQ1 ’19Q2 ’19: $2MQ2 ’19Q3 ’19: $8MQ3 ’19Q4 ’20: $724,000Q4 ’20Q2 ’21: $222,000Q2 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q2 2021398$222,000+9.63%
Q4 20201.5K$724,000+3.35%
Q3 201927.2K$8M+0.38%
Q2 20195.4K$2M+0.10%
Q1 20194.8K$2M+0.12%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See A.r.t. Advisors, LLC’s full portfolio or all institutional holders of REGN.